February 4, 2019

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

[vc_row][vc_column][vc_column_text] Cell and gene therapies (CGTs) offer an unprecedented opportunity to treat diseases for which existing interventions are inadequate, potentially offering cures for previously terminal illnesses. […]
June 14, 2017

The Future of BioManufacturing: Modular Factories & End-to-End Solutions

November 6, 2014

BioReliance Introduce Advanced In Vitro ADME and Toxicology Services

BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy BioReliance® (, Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services […]
Contact Us